ID   DOBIL-6
AC   CVCL_M490
SY   DOBIL6
DR   Wikidata; Q54831342
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9674742;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Non-secretory.
CC   Doubling time: ~36 hours (PubMed=9674742).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9674742; DOI=10.1046/j.1365-2141.1998.00758.x;
RA   Ohmori M., Nagai M., Fujita M., Dobashi H., Tasaka T., Yamaoka G.,
RA   Kawanishi K., Taniwaki M., Takahara J.;
RT   "A novel mature B-cell line (DOBIL-6) producing both parathyroid
RT   hormone-related protein and interleukin-6 from a myeloma patient
RT   presenting with hypercalcaemia.";
RL   Br. J. Haematol. 101:688-693(1998).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//